Skip to main content

NCI: Breast Cancer Cases Could Rise by 50 Percent

A National Cancer Institute model forecasts a marked increase in estrogen receptor-positive tumors among older women by 2030.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, NCIAs the population of the U.S. grows and the average citizen lives longer, the total number of breast cancer cases among American women could be as much as 50 percent greater in 2030 than it was in 2011, according to a new forecast by the National Cancer Institute (NCI). NCI biostatistician Philip Rosenberg presented the findings yesterday (April 20) at the annual meeting of the American Association for Cancer Research (AACR) being held in Philadelphia.

Rosenberg explained that he NCI model predicts that the proportion of estrogen receptor (ER)-positive, in-situ breast cancer may rise from 19 percent to 29 percent, while rates of ER-negative breast cancer diagnoses will plateau or decrease. “Our estimate is that the total number of diagnoses of breast cancer in the U.S. will increase by about 50 percent by 2030,” he said during a press conference announcing the results. “The one silver lining is that we expect fewer ER-negative tumors, which include the most difficult-to-treat HER2-positive and triple-negative subtypes,” Rosenberg added in a statement.

The total number of new breast cancer cases in the U.S. will likely increase from 283,000 in 2011 to 441,000 in 2030, according to the NCI model, which incorporated data from the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays